I never doubted this was the case, and it goes further - is it not likely that support for research has a similar influence? As the state-sponsored funding streams dry up, medical research is falling completely under the influence of Big Pharma.
And - even worse - the people who run our governments are subject to similar enticements, and the rules restricting this are less strict than those demanding "CoI" declarations in medical research
Median payments of $45 and $61 tied to prescribing in the Mitchell JCO study are hard to wave away. The Cochrane review of 93 studies published October 9 points the same way across specialties.
Nice piece! Be careful however concerning patients, as industry is already actively attempting at influencing patients through initiatives such as https://eupati.eu/
It’s what the payment from the pharma sales rep gets in return for the $45-$61 dollar meal, which is a typical lunch cost, access and time. As a former rep, my meal cost wasn’t the differentiator, it was the increased access and time I got with the prescriber. It may have only been 15 minutes, but that is the same time allotted to a typical office visit for a patient. For anyone in the United States wondering their doctor receives from medical device or pharma, go to CMS Open Payments.
I never doubted this was the case, and it goes further - is it not likely that support for research has a similar influence? As the state-sponsored funding streams dry up, medical research is falling completely under the influence of Big Pharma.
And - even worse - the people who run our governments are subject to similar enticements, and the rules restricting this are less strict than those demanding "CoI" declarations in medical research
Simply eliminate all forms of payment from Pharm industry to health care researchers and providers...period.
Median payments of $45 and $61 tied to prescribing in the Mitchell JCO study are hard to wave away. The Cochrane review of 93 studies published October 9 points the same way across specialties.
Nice piece! Be careful however concerning patients, as industry is already actively attempting at influencing patients through initiatives such as https://eupati.eu/
It’s what the payment from the pharma sales rep gets in return for the $45-$61 dollar meal, which is a typical lunch cost, access and time. As a former rep, my meal cost wasn’t the differentiator, it was the increased access and time I got with the prescriber. It may have only been 15 minutes, but that is the same time allotted to a typical office visit for a patient. For anyone in the United States wondering their doctor receives from medical device or pharma, go to CMS Open Payments.